USX:BBIO - BridgeBio Pharma Inc BridgeBio Pharma Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 23 Feb 2022
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 38.62    -1.410 (-3.52%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

3 Dec 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Neil Kumar Ph.D.

IPO: 2019-06-27

Headquarters: US

Employees: 385

Homepage

Description

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.